Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.19 USD | -0.08% | +6.09% | +11.32% |
03-13 | Top Premarket Decliners | MT |
03-12 | JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.32% | 439M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- Wedbush Adjusts iTeos Therapeutics Price Target to $18 From $25, Maintains Outperform Rating